The relationship between biochemical failure and time to nadir in patients treated with external beam therapy for T1-T3 prostate carcinoma
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference20 articles.
1. Cox, D. Regression models and life tables (with discussion). J. R. Stat. Soc. B. 34: 187–220, 1972.
2. Critz, F.A., Levinson, A.K., Williams, W.H. and Holiday, D.A. Prostate-specific antigen nadir: the optimum level after irradiation for prostate cancer. J. Clin. Oncol. 4(11): 2893–2900, 1996.
3. D'Amico, A.V. and Hanks, G.E. Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer. Cancer 72(9): 2638–2643, 1993.
4. Frazier, H.A., Robertson, J.E., Humphrey, P.A. and Paulson, D.F. Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy. J. Urol. 149: 516–518, 1993.
5. Hudson, M.A., Bahnson, R.R. and Catalona, W.J. Clinical use of prostate specific antigen in patients with prostate cancer. J. Urol. 142: 1011, 1989.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prostate‐specific antigen nadir and testosterone level at prostate‐specific antigen failure following radiation and androgen suppression therapy for unfavorable‐risk prostate cancer and the risk of all‐cause and prostate cancer–specific mortality;Cancer;2021-04-06
2. Radical dose escalation by high-dose-rate brachytherapy for localized prostate cancer—Significance of prostate-specific antigen nadir level within 18 months as correlation for long-term biochemical control;Brachytherapy;2019-01
3. Surrogate endpoints in early prostate cancer research;Translational Andrology and Urology;2018-06
4. Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy;Seminars in Radiation Oncology;2017-01
5. Time to Nadir PSA;American Journal of Clinical Oncology;2015-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3